Clinical trial

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

NCT07730021

Study summary

ClinicalTrials.gov

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention ASP388B Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Pembrolizumab Normalized identity: pembrolizumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Oxaliplatin Normalized identity: oxaliplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 5-fluorouracil Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-02

PhasePHASE1 / PHASE2

Conditions

Locally Advanced or Metastatic Solid Tumorsunresolved

Interventions

ASP388BDRUG

PembrolizumabDRUG · verified · RxNorm: pembrolizumab

CarboplatinDRUG · verified · RxNorm: carboplatin

OxaliplatinDRUG · verified · RxNorm: oxaliplatin

5-fluorouracilDRUG

Sponsors & collaborators

Astellas Pharma Global Development, Inc.lead sponsor

Mapped research locations

FairfaxVirginia, United States1 Lake SuccessNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07730021 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.